| JBI Critical Appraisal Checklist: | For Analytical Cross-sectional Studies | For randomized controlled trials |
|---|---|---|
| Q1 | Were the criteria for inclusion in the sample clearly defined? | Was true randomization used for assignment of participants to treatment groups? |
| Q2 | Were the study subjects and the setting described in detail? | Was allocation to treatment groups concealed? |
| Q3 | Was the exposure measured in a valid and reliable way? | Were treatment groups similar at the baseline? |
| Q4 | Were objective, standard criteria used for measurement of the condition? | Were participants blind to treatment assignment? |
| Q5 | Were confounding factors identified? | Were those delivering treatment blind to treatment assignment? |
| Q6 | Were strategies to deal with confounding factors stated? | Were outcomes assessors blind to treatment assignment? |
| Q7 | Were the outcomes measured in a valid and reliable way? | Were treatment groups treated identically other than the intervention of interest? |
| Q8 | Was appropriate statistical analysis used? | Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and analyzed? |
| Q9 | Were participants analyzed in the groups to which they were randomized? | |
| Q10 | Were outcomes measured in the same way for treatment groups? | |
| Q11 | Were outcomes measured in a reliable way? | |
| Q12 | Was appropriate statistical analysis used? | |
| Q13 | Was the trial design appropriate, and any deviations from the standard RCT design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial? | |
Yes / NoUnclear / Not applicable